{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:36:16Z","timestamp":1773416176846,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Despite availability of multiple FDA approved therapies, many children with juvenile idiopathic arthritis (JIA) suffer pain and disability due to uncontrolled disease. The term JIA includes a heterogeneous set of conditions unified by chronic inflammatory arthritis, collectively affecting 1:1,000 children. When reviewing treatment options with families the rheumatologist currently refers to the experience of the average patient in relatively small controlled clinical trials, to consensus-based treatment plans, or increasingly the choice is dictated by the formulary restrictions of insurance payers. The current paradigm for treatment selection does not incorporate real-world evidence of treatment effectiveness centered to the individual patients with whom decisions are to be made. Treatment decisions based on the evidence of the average patient are not optimized to reflect the unique clinical characteristics of an individual with JIA and their disease course, nor does it account for heterogeneous treatment effects. To guide treatment choices centered around each patient, we describe a novel concept of utilizing digital health technology to bring patient-centered information into shared decision-making discussions based on comparative effectiveness analysis of electronic health record or observational clinical registry data of patients with similar characteristics. The envisioned digital tool will organize and present data relevant to the individual patient and enable evidence-based individualized treatment decision making when used in a collaborative manner with the patient family and rheumatologist. Capabilities in digital health technology, data capturing, and analytical methodologies are ripe for this endeavor. This brings the concept of a learning health system directly to the point of care.<\/jats:p>","DOI":"10.3389\/fped.2024.1457538","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:31:08Z","timestamp":1729830668000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Digital health technology to support patient-centered shared decision making at point of care for juvenile idiopathic arthritis"],"prefix":"10.3389","volume":"12","author":[{"given":"Bin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kouril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy M.","family":"Daraiseh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa L.","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esi M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B2","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S2352-4642(19)30027-6","article-title":"Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study","volume":"3","author":"Consolaro","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/art.11156","article-title":"Understanding the window of opportunity concept in early rheumatoid arthritis","volume":"48","author":"Boers","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/art.40519","article-title":"Long-term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition","volume":"70","author":"Shoop-Worrall","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B6","first-page":"35","article-title":"Estimation and reporting of heterogeneity of treatment effects","volume-title":"Developing a Protocol for Observational Comparative Effectiveness Research: A User\u2019s Guide","author":"Varadhan","year":"2013"},{"key":"B7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Subgroup analysis in randomised controlled trials: importance, indications, and interpretation","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1198\/jcgs.2010.08162","article-title":"Bayesian nonparametric modeling for causal inference","volume":"20","author":"Hill","year":"2011","journal-title":"J Comput Graph Stat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","article-title":"Estimation and inference of heterogeneous treatment effects using random forests","volume":"113","author":"Wager","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1541-0420.2005.00377.x","article-title":"Doubly robust estimation in missing data and causal inference models","volume":"61","author":"Bang","year":"2005","journal-title":"Biometrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1214\/088342305000000151","article-title":"Semiparametric estimation of treatment effect in a pretest-posttest study with missing data","volume":"20","author":"Davidian","year":"2005","journal-title":"Stat Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1214\/07-STS227","article-title":"Demystifying double robustness: a comparison of alternative strategies for estimating a population mean from incomplete data","volume":"22","author":"Kang","year":"2007","journal-title":"Stat Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/sim.1903","article-title":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study","volume":"23","author":"Lunceford","year":"2004","journal-title":"Stat Med"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.25302\/11.2020.ME.140819894","volume-title":"New Statistical Methods to Compare the Effectiveness of Adaptive Treatment Plans","author":"Huang","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1122114","DOI":"10.3389\/fams.2023.1122114","article-title":"GPMatch: a Bayesian causal inference approach using Gaussian process covariance function as a matching tool","volume":"9","author":"Huang","year":"2003","journal-title":"Front Appl Math Stat"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v085.i07","article-title":"Beanz: an R package for Bayesian analysis of heterogeneous treatment effects with a graphical user interface","volume":"85","author":"Wang","year":"2018","journal-title":"J Stat Softw"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/sim.7276","article-title":"Subgroup finding via Bayesian additive regression trees","volume":"36","author":"Sivaganesan","year":"2017","journal-title":"Stat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/sim.7970","article-title":"Estimating heterogeneous treatment effects for latent subgroups in observational studies","volume":"38","author":"Kim","year":"2019","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2307\/3350391","article-title":"Organizing care for patients with chronic illness","volume":"74","author":"Wagner","year":"1996","journal-title":"Milbank Q"},{"key":"B20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","article-title":"Treating juvenile idiopathic arthritis to target: recommendations of an international task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/rheumatology\/keq195","article-title":"Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome","volume":"49","author":"Schipper","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-020-00485-y","article-title":"Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention","volume":"18","author":"Chang","year":"2020","journal-title":"Pediatr Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2023061832","DOI":"10.1542\/peds.2023-061832","article-title":"Pediatric decision making: consensus recommendations","volume":"152","author":"Salter","year":"2023","journal-title":"Pediatrics"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooae136","volume-title":"Evidence- and Consensus-Based Digital Healthcare Equity Framework","author":"Hatef","year":"2024"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/acr.25168","article-title":"Pediatric rheumatology care and outcomes improvement network\u2019s quality measure set to improve care of children with juvenile idiopathic arthritis","volume":"75","author":"Bingham","year":"2023","journal-title":"Arthritis Care Res"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1457538\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T07:19:17Z","timestamp":1732951157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1457538\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":25,"alternative-id":["10.3389\/fped.2024.1457538"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1457538","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"article-number":"1457538"}}